- Type / Class
- Equity / Common Stock
- Shares outstanding
- 82,201,196
- Total 13F shares
- 74,070,140
- Share change
- -242,631
- Total reported value
- $401,203,753
- Put/Call ratio
- 89%
- Price per share
- $5.42
- Number of holders
- 149
- Value change
- -$6,558,607
- Number of buys
- 79
- Number of sells
- 62
Quarterly Holders Quick Answers
What is CUSIP 30233G209?
CUSIP 30233G209 identifies EYPT - EyePoint, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 30233G209:
Top shareholders of EYPT - EyePoint, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| EW Healthcare Partners, L.P. |
3/4/5
|
Other*, 10%+ Owner |
—
class O/S missing
|
3,490,921
|
$87,327,483 | — | 01 Sep 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
10%
|
8,325,000
|
$62,021,250 | — | 31 Dec 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
8.3%
|
6,783,091
|
$50,534,028 | — | 31 Dec 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
7%
|
5,750,000
|
$42,837,500 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
6.4%
|
5,281,375
|
$39,346,244 | — | 31 Dec 2024 | |
| FRANKLIN RESOURCES INC |
13F
13D/G
|
Company |
6.1%
from 13D/G
|
4,137,567
|
$30,824,872 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.6%
|
3,803,227
|
$28,334,041 | — | 31 Dec 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
4.5%
|
3,707,445
|
$27,620,465 | — | 31 Dec 2024 | |
| TCG Crossover Management, LLC |
13F
|
Company |
4.3%
|
3,572,335
|
$26,613,896 | — | 31 Dec 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
13D/G
|
Company |
4.7%
from 13D/G
|
3,181,818
|
$23,704,544 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3%
|
2,466,866
|
$18,378,151 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.6%
|
2,144,747
|
$15,980,000 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2%
|
1,662,421
|
$12,385,037 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
1,538,902
|
$11,467,237 | — | 31 Dec 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.9%
|
1,537,274
|
$11,452,691 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.8%
|
1,491,667
|
$11,112,919 | — | 31 Dec 2024 | |
| Patient Square Capital LP |
13F
|
Company |
1.7%
|
1,410,331
|
$10,506,966 | — | 31 Dec 2024 | |
| Essex Woodlands Management, Inc. |
13F
|
Company |
1.4%
|
1,169,857
|
$8,715,435 | — | 31 Dec 2024 | |
| Finepoint Capital LP |
13F
|
Company |
1.4%
|
1,111,104
|
$8,277,725 | — | 31 Dec 2024 | |
| 5AM Venture Management, LLC |
13F
|
Company |
1.3%
|
1,050,000
|
$7,822,500 | — | 31 Dec 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1%
|
857,853
|
$6,391,005 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.91%
|
745,395
|
$5,553,193 | — | 31 Dec 2024 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
0.81%
|
667,594
|
$4,973,575 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.79%
|
648,030
|
$4,827,826 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.78%
|
643,157
|
$4,791,520 | — | 31 Dec 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.73%
|
600,000
|
$4,470,000 | — | 31 Dec 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.7%
|
579,500
|
$4,317,275 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.69%
|
570,026
|
$4,246,694 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.61%
|
501,724
|
$3,737,844 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.54%
|
446,199
|
$3,324,183 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.48%
|
395,444
|
$2,946,058 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.43%
|
353,954
|
$2,636,957 | — | 31 Dec 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.43%
|
351,348
|
$2,617,543 | — | 31 Dec 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.42%
|
348,000
|
$2,592,600 | — | 31 Dec 2024 | |
| Therapeutics Ocumension |
3/4/5
|
Director |
—
class O/S missing
|
100,221
|
$2,507,088 | — | 11 Jan 2024 | |
| Ye Liu |
3/4/5
|
Director |
—
class O/S missing
|
100,221
|
$2,507,088 | — | 11 Jan 2024 | |
| Principia Wealth Advisory, LLC |
13F
|
Company |
0.33%
|
270,382
|
$2,014,346 | — | 31 Dec 2024 | |
| AXA S.A. |
13F
|
Company |
0.32%
|
263,143
|
$1,960,415 | — | 31 Dec 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.31%
|
257,615
|
$1,918,013 | — | 31 Dec 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.33%
|
270,336
|
$1,897,759 | — | 31 Dec 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.28%
|
230,745
|
$1,719,050 | — | 31 Dec 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.27%
|
223,641
|
$1,666,125 | — | 31 Dec 2024 | |
| Artia Global Partners LP |
13F
|
Company |
0.26%
|
216,700
|
$1,614,415 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.26%
|
213,382
|
$1,589,696 | — | 31 Dec 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
0.25%
|
206,939
|
$1,542,000 | — | 31 Dec 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.25%
|
205,578
|
$1,531,556 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.25%
|
204,260
|
$1,521,735 | — | 31 Dec 2024 | |
| David Scott Jones |
3/4/5
|
SVP & Chief Commercial Officer |
—
mixed-class rows
|
54,291
mixed-class rows
|
$1,437,581 | — | 09 Feb 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.23%
|
191,165
|
$1,424,179 | — | 31 Dec 2024 | |
| Dario A. Paggiarino |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
68,106
mixed-class rows
|
$1,386,544 | — | 30 Mar 2024 |
Institutional Holders of EyePoint, Inc. - Common Stock (EYPT) as of Q1 2025
As of 31 Mar 2025,
EyePoint, Inc. - Common Stock (EYPT) was held by
149 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
74,070,140 shares.
The largest 10 holders included
Cormorant Asset Management, LP, SUVRETTA CAPITAL MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc., FRANKLIN RESOURCES INC, FEDERATED HERMES, INC., VANGUARD GROUP INC, TCG Crossover Management, LLC, RA CAPITAL MANAGEMENT, L.P., and CITADEL ADVISORS LLC.
This page lists
149
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
141
Q1 2025 holders
149
Holder diff
8
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.